| |
| |
|
| Insider
Information: |
Cohen Kenneth M |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
721,083 |
|
|
Indirect Shares
|
98,795 |
|
|
| Direct
Value |
$3,161 |
|
|
|
Indirect Value
|
$1,980 |
|
|
| Total
Shares |
819,878 |
|
|
| Total
Value |
$5,141 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
President and CEO, Dir... |
2007-10-08 |
20,000 |
2007-10-08 |
38,795 |
Premium* |
|
|
Adamis Pharmaceuticals Corp |
ADMP |
Director |
2013-03-06 |
19,776 |
2013-03-06 |
50,000 |
Premium* |
|
|
RespireRx Pharmaceuticals Inc |
RSPI |
|
2013-03-22 |
656,755 |
|
0 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
|
2018-04-02 |
24,552 |
2016-04-04 |
10,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
• • – |
2005-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
120,833 |
|
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-09-25 |
4 |
AS |
$12.84 |
$47,356 |
I/I |
(3,689) |
117,114 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-09-26 |
4 |
AS |
$12.62 |
$16,548 |
I/I |
(1,311) |
115,833 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-10-02 |
4 |
AS |
$12.62 |
$6,626 |
I/I |
(525) |
115,308 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-10-04 |
4 |
AS |
$12.50 |
$1,050 |
I/I |
(84) |
115,224 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-10-05 |
4 |
AS |
$12.57 |
$15,321 |
I/I |
(1,219) |
114,005 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-10-06 |
4 |
AS |
$13.15 |
$41,715 |
I/I |
(3,172) |
110,833 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-10-23 |
4 |
AS |
$15.03 |
$1,773 |
I/I |
(118) |
110,715 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-11-01 |
4 |
AS |
$14.45 |
$72,269 |
I/I |
(5,000) |
105,715 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-11-07 |
4 |
AS |
$15.00 |
$750 |
I/I |
(50) |
105,665 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-11-13 |
4 |
AS |
$15.11 |
$6,014 |
I/I |
(398) |
105,267 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-11-14 |
4 |
AS |
$15.03 |
$15,710 |
I/I |
(1,045) |
104,222 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-11-15 |
4 |
AS |
$15.02 |
$961 |
I/I |
(64) |
104,158 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-12-01 |
4 |
AS |
$13.10 |
$65,525 |
I/I |
(5,000) |
99,158 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-12-18 |
4 |
AS |
$15.03 |
$22,578 |
I/I |
(1,502) |
97,656 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-12-19 |
4 |
AS |
$15.00 |
$70,700 |
I/I |
(4,713) |
92,943 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2006-12-20 |
4 |
AS |
$15.00 |
$49,739 |
I/I |
(3,315) |
89,628 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-01-03 |
4 |
AS |
$13.47 |
$67,369 |
I/I |
(5,000) |
84,628 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-02-15 |
4 |
AS |
$12.96 |
$64,791 |
I/I |
(5,000) |
79,628 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-03-14 |
4 |
AS |
$12.53 |
$62,629 |
I/I |
(5,000) |
74,628 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-04-05 |
4 |
AS |
$12.50 |
$2,500 |
I/I |
(200) |
74,428 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-04-09 |
4 |
AS |
$12.55 |
$60,222 |
I/I |
(4,800) |
69,628 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-04-25 |
4 |
AS |
$15.14 |
$360,180 |
I/I |
(23,795) |
45,833 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-05-11 |
4 |
OE |
$1.20 |
$18,000 |
I/I |
15,000 |
38,795 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
President and CEO |
• • – |
2007-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
